...
首页> 外文期刊>Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases >First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil
【24h】

First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil

机译:第一次见解巴西南部循环XDR和XDR前XDR的结核分枝杆菌

获取原文
获取原文并翻译 | 示例
           

摘要

Drug-resistant tuberculosis (DR-TB) is major problem in the fight against TB. Multidrug resistant (MDR) TB patients have a reduced treatment success rates and for, extensively drug-resistant (XDR) TB the cure rate does not exceed 25% in many countries. To evaluate the pre-XDR-TB and XDR-TB prevalence and transmission in Rio Grande do Sul State, in southern Brazil, we performed a retrospective WGS-based analysis of 87 MDR-TB cases, aiming to identify resistance-conferring mutations and its phylogenetic distinctiveness. Using a five SNP threshold for genomic clustering, 60 strains were genomically linked within 10 clusters, including 14 likely transmission events identified by retrospective conventional epidemiological investigation. Moreover, five likely transmission events involved 17 patients deprived of liberty in the same prison establishment. Mutations associated with isoniazid and rifampicin resistance were identified respectively in 97.70% and 98.85% of MDR M.tb strains, more frequently in katG and rpoB genes. In total, we identified eight (9.19%) pre-XDR and four (4.59%) XDR M.tb strains. Resistance to ofloxacin was observed in seven (8.04%) strains, all of them presenting resistance-conferring mutations. Phenotypic resistance from capreomycin and kanamycin was found in seven (8.04%) and four (4.59%) strains respectively, but no classic mutations associated with resistance to these drugs was identified. The results put in evidence a scenario involving multiple phylogenetically distinctive clades associated with pre-XDR and XDR-TB in the largest state of southern Brazil, while stressing the potential of using WGS to predict anti-TB drug resistance and need to halt MDR-TB transmission in the region.
机译:耐药结核病(DR-TB)是对抗结核病的主要问题。多药抗性(MDR)TB患者的治疗成功率降低,耐药性(XDR)结核病治愈率在许多国家的治愈率不超过25%。为了评估XDR-TB和XDR-TB患病率和传播在巴西南部的RIO Grande Do Sul State,我们对87名MDR-TB病例进行了回顾性的基于WGS分析,旨在识别抵抗抵抗突变及其系统发育独特性。使用五个SNP阈值进行基因组聚合物,60株在10个簇内基因组合,包括通过回顾性传统流行病学调查确定的14个可能的传动事件。此外,五个可能的传输事件涉及17名患者在同一监狱建立中剥夺了自由。分别在97.70%和98.85%的MDR M.TB菌株中分别鉴定与异噻唑和利福平抗性相关的突变,在KATG和RPOB基因中更常见。总共确定了八(9.19%)预XDR和四(4.59%)XDR M.TB菌株。在七(8.04%)菌株中观察到对氧氟沙星的抗性,所有这些菌株呈现出抗性赋予抗性突变。分别在七(8.04%)和四(4.59%)菌株中发现来自辣椒素和卡那霉素的表型抗性,但鉴定了与对这些药物的抗性相关的经典突变。结果提出了涉及与巴西最大状态的XDR和XDR-TB相关的涉及多个系统源和XDR-TB的情景,同时强调使用WG预测抗结核病耐药性并且需要停止MDR-TB的潜力传输在该地区。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号